.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Teva
Chubb
Fuji
Medtronic
QuintilesIMS
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo

Generated: February 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to France Patent: 97 00479

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie IncTRICORfenofibrateTABLET;ORAL021203-001Sep 4, 2001DISCNYesNo➤ Sign Up➤ Sign Up
Abbvie IncTRICORfenofibrateTABLET;ORAL021203-003Sep 4, 2001DISCNYesNo➤ Sign Up➤ Sign Up
AbbvieTRICORfenofibrateTABLET;ORAL021656-001Nov 5, 2004ABRXYesNo➤ Sign Up➤ Sign UpY
AbbvieTRICORfenofibrateTABLET;ORAL021656-002Nov 5, 2004ABRXYesYes➤ Sign Up➤ Sign UpY
Abbvie IncTRICORfenofibrateTABLET;ORAL021203-001Sep 4, 2001DISCNYesNo➤ Sign Up➤ Sign Up
Abbvie IncTRICORfenofibrateTABLET;ORAL021203-003Sep 4, 2001DISCNYesNo➤ Sign Up➤ Sign Up
Abbvie IncTRICORfenofibrateTABLET;ORAL021203-001Sep 4, 2001DISCNYesNo➤ Sign Up➤ Sign Up
Abbvie IncTRICORfenofibrateTABLET;ORAL021203-003Sep 4, 2001DISCNYesNo➤ Sign Up➤ Sign Up
AbbvieTRICORfenofibrateTABLET;ORAL021656-001Nov 5, 2004ABRXYesNo➤ Sign Up➤ Sign UpY
AbbvieTRICORfenofibrateTABLET;ORAL021656-002Nov 5, 2004ABRXYesYes➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist